Evidence Hub

Efficacy of the Transdiagnostic Intervention for Sleep and Circadian Dysfunction for depression symptoms and sleep-wake disruption in older and younger adults: secondary age-stratified analysis of a randomized controlled trial

Stephen F. Smagula, C. Gasperetti, Daniel J. Buysse, M. R. Irwin, Robert T. Krafty, Sarah E Lim, Charles F. Reynolds, W. McCall et al.

The American journal of geriatric psychiatry, 2023

52 participants · 7 citations

Abstract

Objective: Perform a secondary analysis examining the efficacy of the Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) for depression symptom responses, and explore changes in potential target mechanisms. Design: Secondary analysis of a randomized controlled trial with convenience age subsamples (younger (20-49 year; n=52) versus and older (50-71 years; n=35)). Setting: Community mental health clinics Participants: Eighty-seven adults with serious mental illness Intervention: TranS-C versus treatment as usual (TAU) Measurements: Outcomes were depression symptoms (Quick Inventory of Depression Symptoms), insomnia symptoms (Insomnia Severity Index), and objective sleep-wake rhythm measures (inter-daily stability and relative amplitude). Results: Depression response rates (≥50% symptom reductions) were higher in the TranS-C (35.0%) than the TAU (8.8%) group six-months post-intervention (Chi-square =10.3, p=0.001). There was a medium effect of TranS-C versus TAU on depression symptoms six-months post-intervention (Cohen’s d=−0.40, 95% confidence interval (CI): −0.81, 0.01). In both age groups, there were large treatment effects on insomnia symptoms post-treatment (Cohen’s d>0.90). In the older subsample, there were additionally medium treatment effects on post-treatment inter-daily stability (Cohen’s d=0.60, 95% CI: −0.11, 1.61). Post-treatment reductions in insomnia symptoms correlated with depression symptom reduction six-months later in the younger…

How strong is the evidence?

Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 52 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free